J. Roberts and Marcia Fosberg Distinguished Regents Professor of Pharmacotherapy and Director of the Drug Information Center Danial Baker with five co-authors published, “Impact of educational intervention in evidence-based drug information in interprofessional practice at a tertiary-level care hospital,” in the Journal of Interprofessional Education and Practice online in January, 2022.
Danial Baker and Pharmacotherapy Clinical Professor and Director of Quality Assurance Improvement & Accreditation Preparation Terri Levien published, “Drug evaluation – avacopan (Tavneos): updated evaluation,” in Wolters Kluwer Health’s The Formulary Monograph Service (FMS) in January 2022. Wolters Kluwer Health is a drug and health information publisher, the FMS is a resource used in the formulary decision making process for hospitals and managed care systems on recently released and investigational drugs.
Danial Baker published, “Drug evaluation – tisotumab vedotin-tftv (Tivdak),” in the FMS in January 2022.
Terri Levien and Danial Baker published, “Drug evaluation – varenicline solution nasal spray (Tyrvaya),” in the FMS in January 2022.
Drug Information Center Resident Regan Smith, Terri Levien and Danial Baker with student co-author Victoria Chase (PharmD class of 2022) published, “Drug evaluation – lonapegsomatropin-tcgd (Skyrizi),” in the FMS in January 2022.
Regan Smith, Terri Levien and Danial Baker with student co-author Kellyan Nguyen (PharmD class of 2022) published, “Drug evaluation – mobocertinib succinate (Exkivity),” in the FMS in January 2022.
Danial Baker published, “Drug utilization evaluation – avacopan (Tavneos),” in the FMS in January 2022.
Pharmacotherapy Associate Professor Megan Undeberg, Pharmacotherapy Associate Professor and Director for the Center for Pharmacy Practice Research Kimberly McKeirnan, and one co-author published, “Respecting the patient’s choice: a case of possible drug-induced parkinsonism,” in Pharmacy —A Journal of Pharmacy Education and Practice in January 2022.
Kimberly McKeirnan, Adriel Supnet (‘21 PharmD) and Connor Capdeville (‘21 PharmD) published, “Exploring the relationship between stress and student leadership among student pharmacists,” in Currents in Pharmacy Teaching and Learning in December 2021.
Allen I. White Distinguished Associate Professor of Pharmacotherapy Joshua Neumiller with three co-authors published the book chapter, “Glucagon-like peptide-1 receptor agonists (GLP1-RA),” in the second edition of Diabetes and Kidney Disease.
Associate Dean for External Relations and Pharmacotherapy Associate Professor Julie Akers, Elson S. Floyd College of Medicine Collaboration for InterProfessional Health Education Research & Scholarship Coordinator Jennifer Anderson, Elson S. Floyd College of Medicine Director of Interprofessional Education & Research Barbara Richardson and Brandy Seignemartin (’20 PharmD) published, “New interprofessional health sciences precepting legislation provides opportunity to assess student and preceptor knowledge, experience, and confidence,” in the Journal of Interprofessional Education & Practice in June 2022.
Pharmaceutical Sciences Associate Professor Sue Marsh taught cardiovascular physiology to two seventh-grade science classes at the Institute of Science and Technology at North Central High School on December 6, 2021.
Josh Neumiller has been appointed for a two-year term on the American Diabetes Association’s (ADAs) Science and Healthcare Executive Council. The Science and Healthcare Executive Council is advisory to the ADA Board of Directors through the Chief Science and Medical Officer (CSMO) and the Chief Executive Officer (CEO). The Council is co-chaired by the ADA Presidents of Medicine and Science and Health Care and Education.
Josh Neumiller was acknowledged as an expert consultant for the development of the 2022 American Diabetes Association (ADA) Standards of Medical Care in Diabetes.
Pharmaceutical Sciences and Molecular Medicine students
Deepak Ahire (Prasad lab) with faculty co-author Pharmaceutical Sciences Associate Professor and Director of Industry Engagement Bhagwat Prasad and four others published, “Inter-individual variability and differential tissue abundance of mitochondrial amidoxime reducing component (mARC) in humans,” in the peer-reviewed, Journal of Drug Metabolism and Disposition in December 2021.
Doctor of Pharmacy (PharmD) students
Karen Vo, a third-year PharmD student in the Paine lab, was selected to participate in the FDA Pharmacy Student Experiential Program, of which the goal is to provide an opportunity to learn about the FDA’s multidisciplinary processes for addressing public health issues involving drugs, biologics, and medical devices. She will be working with the pediatrics group within the Office of Clinical Pharmacology in fall 2022 as part of her fourth-year Advanced Pharmacy Practice Experience (APPE) requirements.
Victoria Chase (class of 2022) with faculty co-authors Regan Smith, Terri Levien and Danial Baker published, “Drug evaluation – lonapegsomatropin-tcgd (Skyrizi),” in the FMS in January 2022.
Kellyan Nguyen (class of 2022) with faculty co-authors Regan Smith, Terri Levien and Danial Baker published, “Drug evaluation – mobocertinib succinate (Exkivity),” in the FMS in January 2022.